Alba A. Brandes
0000-0002-2503-9089
Publication & Citation Trends
Publications
0 total
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.
Cited by 0
Semantic Scholar
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis
Cited by 0
Semantic Scholar
Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial
Cited by 0
Semantic Scholar
Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trial
Cited by 0
Semantic Scholar
BIOM-09. PROGNOSTIC AND PREDICTIVE MARKERS FOR OUTCOME IN PATIENTS WITH IDHMT TUMORS TREATED IN THE EORTC CATNON TRIAL ON ADJUVANT AND/OR CONCURRENT TEMOZOLOMIDE IN ANAPLASTIC ASTROCYTOMA
Cited by 0
Semantic Scholar
QOL-26. Health-Related Quality of Life in Molecular Glioma Subtypes: A Pooled Analysis from 16 Randomized Trials
Cited by 0
Semantic Scholar
Final clinical and molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion: NCT00626990.
Cited by 1
Semantic Scholar
OS04.2.A FINAL CLINICAL AND MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1P/19Q CODELETION.
Cited by 0
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(474)
Brain Metastases and Treatment
(195)
Radiomics and Machine Learning in Medical Imaging
(89)
Cancer, Hypoxia, and Metabolism
(61)
Meningioma and schwannoma management
(53)
Affiliations
Ontario Institute for Cancer Research
Goethe University Frankfurt
University of Verona
European Organisation for Research and Treatment of Cancer
Seattle Children's Hospital